Quantcast

Latest Mammalian target of rapamycin Stories

2014-06-30 23:19:26

The Life, Earth & Health Sciences Magazine has reorganized its structure to facilitate interaction with users. EurekaMag.com's new interface enables users to upload their science content for a new, private and spam-free web experience. Mannheim, Germany (PRWEB) June 30, 2014 EurekaMag.com has introduced a new structure and new approach to publishing science content. Due to many requests from its users, researchers can now upload their science content without sacrificing their...

2014-06-05 20:22:51

More than 70 Experts Deliver Findings in mTor, Circadian Rhythm, Animal Aging and FAT10 SAN ANTONIO, June 5, 2014 /PRNewswire-USNewswire/ --The 43(rd) Annual Meeting of the American Aging Association (AGE) held May 30-June 2, 2014, in San Antonio, Texas, featured the latest scholarship in the field of aging research from more than 70 leading experts. "The talks at this year's meeting were of exceptionally high quality with new exciting insights on the role of gut fauna in healthy aging,...

2014-05-26 13:16:33

Albert Einstein College of Medicine Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a signaling pathway in cancer cells that controls their ability to invade nearby tissues in a finely orchestrated manner. The findings offer insights into the early molecular events involved in metastasis, the deadly spread of cancer cells from primary tumor to other parts of the body. The study was published today in the online edition of Nature Cell Biology. To...

2014-05-20 08:34:22

AADi Initiates NIH Funded Clinical Trial for Patients with Bladder Cancer PACIFIC PALISADES, Calif., May 20, 2014 /PRNewswire/ -- AADi, LLC, a clinical stage biopharmaceutical company focused on treating diseases uniquely suited for nanotechnology approaches, today announced the inlicensing of ABI-009 from Celgene Corporation (NASDAQ:CELG). ABI-009 is the nanoparticle albumin-bound (nab®) version of the mTOR inhibitor sirolimus or rapamycin and leverages the same technology of the...

2014-05-16 12:27:48

MILLBROOK, N.Y., May 16, 2014 /PRNewswire/ -- Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Hans-Guido Wendel, MD, to its Scientific Advisory Committee. Dr. Wendel, a graduate of the University of Aachen, Germany, trained in clinical hemato-oncology in Germany, performed research at Cold Spring Harbor and presently holds a tenure-track position at Sloan Kettering Institute NYC focusing on the genetics of lymphatic cancer and initially...

2014-04-28 23:04:36

Findings Show Several FDA-Approved Drugs May also be Effective in Patients Diagnosed with Dilated Cardiomyopathy New York, NY (PRWEB) April 28, 2014 Scientists at Icahn School of Medicine at Mount Sinai, along with collaborators at institutions in India, Italy, and Japan, have identified the first gene linked to childhood-onset familial dilated cardiomyopathy (DCM), one of the most common heart muscle diseases in children. It is a progressive and potentially fatal heart condition...

2014-04-07 15:48:32

A University of Colorado Cancer Center study recently published in the journal Cell Reports and presented today at the American Association for Cancer Research (AACR) Annual Conference 2014 shows that the cellular process of autophagy in which cells "eat" parts of themselves in times of stress may allow cancer cells to recover and divide rather than die when faced with chemotherapies. Autophagy, from the Greek "to eat oneself," is a process of cellular recycling in which cell organelles...

2014-03-10 04:21:18

Over 200 scientific studies have concluded that curcumin has the propensity to avert prostate cancer. MENTOR, Ohio, March 10, 2014 /PRNewswire-iReach/ -- As a leading developer in liposomal science, MaxHealthLabs is dedicated to producing quality health products. Their new Intra-Cellular Liposomal Curcumin is able to remedy many health disorders, naturally. Curcumin is an active product that is generated from the spice, turmeric. It has been consumed for centuries in other parts of...

2014-02-04 11:07:09

Opening up a can of worms is a good way to start hunting for new drugs, recommend researchers from Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine. In a study published today in the Public Library of Science One, they used a primitive worm model to show that a drug typically used to treat agitation in schizophrenia and dementia has potential as a treatment for α-1 antitrypsin (AT) deficiency, an inherited disease that causes severe liver...

2014-01-31 10:54:35

Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth. The finding could lead to new treatments for osteoporosis and other diseases that occur when the body doesn't make enough bone. Osteoporosis affects 55 percent of Americans age 50 and older. Of that age group, one in three women and one in 12 men are believed to have osteoporosis, a condition responsible for millions of fractures each year, mostly...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related